<description>&lt;p&gt;This week, health editor Michael Smith on why baby-making is such big business and how private equity firms are reshaping the IVF sector.&lt;/p&gt; &lt;p&gt;This podcast is sponsored by&amp;nbsp;&lt;a href="https://www.acenda.com.au/"&gt;Acenda&lt;/a&gt;&amp;nbsp;&lt;/p&gt; &lt;p&gt;Further reading:&lt;br aria-hidden="true"&gt;&lt;strong data-stringify-type="bold"&gt;&lt;a href="https://www.afr.com/companies/healthcare-and-fitness/ill-conceived-inside-australia-s-ivf-money-making-machine-20250806-p5mkwe.html" data-stringify-link="https://www.afr.com/companies/healthcare-and-fitness/ill-conceived-inside-australia-s-ivf-money-making-machine-20250806-p5mkwe.html" data-sk="tooltip_parent"&gt;Ill-conceived: Inside Australia&amp;rsquo;s IVF money-making machine&lt;/a&gt;&lt;/strong&gt;&lt;strong data-stringify-type="bold"&gt;&lt;/strong&gt;&lt;br aria-hidden="true"&gt;The commercialisation of the industry as private equity owners take over from pioneering doctors has many people very worried.&lt;br aria-hidden="true"&gt;&lt;strong data-stringify-type="bold"&gt;&lt;a href="https://www.afr.com/companies/healthcare-and-fitness/monash-ivf-says-genesis-capital-s-300m-takeover-bid-is-too-low-20251124-p5nhsw" data-stringify-link="https://www.afr.com/companies/healthcare-and-fitness/monash-ivf-says-genesis-capital-s-300m-takeover-bid-is-too-low-20251124-p5nhsw" data-sk="tooltip_parent"&gt;Monash IVF rejects $300m takeover bid from Genesis Capital as too low&lt;/a&gt;&lt;/strong&gt;&lt;br aria-hidden="true"&gt;Shares in the fertility group have fallen more than 40 per cent since mistakes were disclosed earlier this year, prompting the PE-led consortium to swoop.&lt;br aria-hidden="true"&gt;&lt;strong data-stringify-type="bold"&gt;&lt;a href="https://www.afr.com/companies/healthcare-and-fitness/monash-ivf-says-market-share-patients-down-since-embryo-mix-ups-20251120-p5nh46" data-stringify-link="https://www.afr.com/companies/healthcare-and-fitness/monash-ivf-says-market-share-patients-down-since-embryo-mix-ups-20251120-p5nh46" data-sk="tooltip_parent"&gt;Monash IVF says market share, patients down since embryo mix-ups&lt;/a&gt;&lt;/strong&gt;&lt;br aria-hidden="true"&gt;Stiff competition and pricing pressure in Victoria has hurt the fertility group&amp;rsquo;s performance so far this fiscal year.&lt;/p&gt;&lt;p&gt;See &lt;a href="https://omnystudio.com/listener"&gt;omnystudio.com/listener&lt;/a&gt; for privacy information.&lt;/p&gt;</description>

The Fin

Australian Financial Review

Ill-conceived: Inside Australia’s IVF money-making machine

JAN 21, 202628 MIN
The Fin

Ill-conceived: Inside Australia’s IVF money-making machine

JAN 21, 202628 MIN

Description

This week, health editor Michael Smith on why baby-making is such big business and how private equity firms are reshaping the IVF sector. This podcast is sponsored by Acenda  Further reading:Ill-conceived: Inside Australia’s IVF money-making machineThe commercialisation of the industry as private equity owners take over from pioneering doctors has many people very worried.Monash IVF rejects $300m takeover bid from Genesis Capital as too lowShares in the fertility group have fallen more than 40 per cent since mistakes were disclosed earlier this year, prompting the PE-led consortium to swoop.Monash IVF says market share, patients down since embryo mix-upsStiff competition and pricing pressure in Victoria has hurt the fertility group’s performance so far this fiscal year.See omnystudio.com/listener for privacy information.